Summary & Overview
CPT 3044F: Hemoglobin A1C Result <7% for Diabetes Control
CPT code 3044F documents a patient’s most recent hemoglobin A1C (HbA1c) level when it is less than 7 percent, signaling glycemic control within a commonly used target range for many adults with diabetes. As a performance and quality tracking code, it is used in clinical records, quality reporting, and payer performance programs to indicate effective diabetes management. Nationally, consistent use of 3044F supports population-level monitoring of diabetes control and ties into value-based care measures and quality incentive programs.
Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will learn how 3044F is applied in clinical documentation and quality reporting, the typical service contexts and sites for the associated HbA1c result, and which payers commonly recognize and include such performance codes in their quality measurement frameworks. The publication also outlines benchmarking and policy implications tied to HbA1c reporting, clinical context for interpreting a value under 7 percent, and areas where data is not available in the input for deeper billing or claims-level details.
Billing Code Overview
CPT code 3044F indicates the most recent glycated hemoglobin measurement (HbA1c) with a result of less than 7 percent. The code documents the patient’s A1C level and is used to indicate that diabetes is within the target control range.
-
Service type: Laboratory result reporting of a point-in-time glycemic control measure (HbA1c test result interpretation and documentation)
-
Typical site of service: Office or clinic visit, outpatient laboratory, or any ambulatory setting where diabetes management and laboratory review occur
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A typical patient is an adult with diagnosed type 2 diabetes mellitus presenting for routine chronic care management in an outpatient primary care or endocrinology clinic. The clinical workflow begins with the medical assistant or nurse obtaining a point-of-care or laboratory blood sample for the hemoglobin A1C (HbA1c) test during the visit. The result is reviewed by the provider during the same encounter or when lab results return; an HbA1c value of less than 7% is documented as the most recent control metric using code 3044F. Documentation includes the test date, numeric HbA1c value, interpretation (e.g., controlled), current diabetes medications, and any medication adjustments or care plan changes. Typical sites of service include outpatient clinics, physician offices, federally qualified health centers, urgent care centers, and laboratory draw stations associated with ambulatory settings. Common patient scenarios include periodic diabetes control visits, medication reconciliation after a therapy change, and chronic care visits coordinated with diabetes self-management education.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
00 | No modifier | Default — used when no other modifier applies |
33 |